FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...

As expected by many, Eli Lilly And Co (NYSE:LLY) filed a motion to intervene as a defendant in a case between the Outsourcing Facilities Association and FarmaKeio Custom Compounding against the FDA.

Get Wall Street's Hottest Chart Every Morning As expected by many, Eli Lilly And Co LLY filed a motion to intervene as a defendant in a case between the Outsourcing Facilities Association and ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

The FDA finalized Monday an interim regulatory policy for outsourcing facilities that compound drugs using bulk drug substances while the agency develops a list of medicines that have a clinical need.

following a proposal by the trade group the Outsourcing Facilities Association (OFA) to add the molecule to its compounding roster. Apart from Victoza, which was approved for Type 2 diabetes in ...

In a Citizen Petition posted on Regulations.gov, Novo Nordisk (NVO) noted that the Outsourcing Facilities Association, or OFA, has nominated liraglutide be added to their list of bulk drug ...

The company highlights that existing FDA-approved formulations lack attributes that would necessitate compounding, while the Outsourcing Facilities Association’s (OFA) nomination relies on ...

The Outsourcing Facilities Association, which represents sites that make compounded medicines, and the Texas-based compounding pharmacy FarmaKeio Custom Compounding filed the lawsuit in October. The ...

BofA Securities maintained an Underperform rating on shares of Hims & Hers Health, Inc. (NYSE:HIMS) with a steady price target of $18.00.